Fig. 5From: Biodegradable and biocompatible subcutaneous implants consisted of pH-sensitive mebendazole-loaded/folic acid-targeted chitosan nanoparticles for murine triple-negative breast cancer treatmentCytotoxic effect of different concentrations (0, 0.5, 1, and 1.5 µM) of MBZ, CS-FA, and CS-FA-MBZ nanoparticles on a 4T1 breast cancer and b L929 normal cells viability after 48 h incubation according to MTT assayBack to article page